Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration (NCT07442669)
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration: A Pilot Study
🩺 Plain-English Summary (8th-Grade Level)
This prospective randomized controlled study aims to determine if using a lung ultrasound score can lead to a faster diagnosis of severe respiratory distress syndrome and quicker administration of surfactant in moderately and late-preterm infants. The research will involve 100 infants, with 67 in the prospective group and 33 serving as controls. The primary goal is to shorten the time to treatment for these vulnerable newborns. The study will also assess whether this ultrasound-guided approach improves short-term respiratory outcomes. These secondary objectives include measuring any decrease in the need for and duration of mechanical ventilation, the length of non-invasive respiratory support, and the overall need for oxygen. The study population includes infants born between 27 and 34 6/7 weeks of gestation who are admitted to the NICU. Each participant will be monitored from birth until they are discharged or transferred. This research aligns with a growing body of evidence suggesting that lung ultrasound can be a valuable tool in neonatal care, potentially leading to earlier and more precise treatment for respiratory distress syndrome.
Who can join: Review the eligibility criteria below.
Location: Hackensack Univeristy Medical Center — Hackensack, New Jersey
Age range: 27 Weeks to 34 Weeks
🧪 Interventions in This Study
- Lung ultrasound (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Hackensack Univeristy Medical Center — Hackensack, New Jersey
📞 Contact the Study Coordinator
Phone: (551) 996-3457
Email: jeanette.haugh@hmhn.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Respiratory Distress Syndrome, Newborn
- Measuring Diaphragm Electrical Activity in Neonates Using a Smaller Inter-electrode Distance — Toronto, Ontario
- Echography-guided Surfactant THERapy (ESTHER) For Preterm Infants With Respiratory Failure — Hartford, Connecticut
- Prophylactic Minimally Invasive Surfactant Evaluation — Evanston, Illinois
- Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting — Rochester, Minnesota
Explore by condition: All Respiratory Distress Syndrome, Newborn clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.